FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/03/2023
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The sign consists of the word SCIRENT, in Latin capital letters, in black. Below the word SCIRENT, there are four words - Clinical Research and Science, in Latin letters, in blue. In the upper right corner, above the word SCIRENT there is a circle in different shades of green and blue (light green, dark green, light blue, dark blue) whose center is painted in white
Titulares
Representantes
Clemens W. Pauly Pauly P.A.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Medical and scientific research and data analysis services; implementation and analysis of clinical trials in the field of medicines, medical devices, biotechnology and natural sciences; development of protocols, scientific consultation, and preparation of reports with respect to medical research; research center project management; local and global clinical trial project management; pharmaceutical drug development services, development of clinical trial methodologies; consultancy services in the field of pharmaceutical clinical trials; extensive clinical research services for others; electronic storage services for clinical trial data; biostatic analysis; services provided by consultants with respect to research in the field of environmental protection, preclinical research and evaluation of pharmaceutical product development; conducting clinical trials for others in the nature of scientific research, especially the correction of clinical trials and defective records; clinical trial services in the nature of strategic management of clinical research portfolios and follow-up of biological monitoring; providing information in the field of natural sciences and scientific research to physicians and other health professionals, to patients and to medical, pharmaceutical and biotechnological companies; providing technical drafting services for complaints and/or disputes in the field of medical research and clinical studies; consultation services in the field of clinical research under contract and product development under contact; design and development of computer hardware as well as consultation services relating thereto for others; creating websites featuring blogs on medical and pharmaceutical information relating to chronic conditions and diseases; creating and maintaining Internet websites for patients and registered care providers to form virtual communities and to engage in the field of health; design and development of an interactive software for use in the communication and dissemination of medical and pharmaceutical information
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
21/03/2023
GENERIC MADRID TRANSACTION SENT TO IB
30/01/2023
GENERIC MADRID TRANSACTION CREATED
30/01/2023
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/01/2023
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/10/2022
REGISTERED-PRINCIPAL REGISTER
11/10/2022
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/07/2022
PUBLISHED FOR OPPOSITION
26/07/2022
NOTIFICATION PROCESSED BY IB
25/07/2022
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2022
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/07/2022
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2022
APPROVED FOR PUB - PRINCIPAL REGISTER
22/06/2022
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2022
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2022
REFUSAL PROCESSED BY IB
06/02/2022
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/01/2022
REFUSAL PROCESSED BY MPU
18/01/2022
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/12/2021
NON-FINAL ACTION WRITTEN
22/12/2021
ASSIGNED TO EXAMINER
15/12/2021
APPLICATION FILING RECEIPT MAILED
01/10/2021
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/09/2021
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/09/2021
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.